Shengyuan Luo1,2, Josef Coresh1,2,3, Adrienne Tin1,2, Casey M Rebholz1,2, Lawrence J Appel1,2,3, Jingsha Chen1,3, Ramachandran S Vasan4, Amanda H Anderson5, Harold I Feldman5,6, Paul L Kimmel7, Sushrut S Waikar8, Anna Köttgen2,9, Anne M Evans10, Andrew S Levey11, Lesley A Inker11, Mark J Sarnak11, Morgan Erika Grams12,3,13. 1. Welch Center for Prevention, Epidemiology, and Clinical Research. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 3. Division of General Internal Medicine, and. 4. Department of Medicine, Boston University School of Medicine, Boston, Massachusetts. 5. Department of Biostatistics, Epidemiology, and Informatics and. 6. Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. 7. Division of Kidney Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. 8. Renal Division, Brigham and Women's Hospital, Boston, Massachusetts. 9. Institute of Genetic Epidemiology, Department of Biometry, Epidemiology and Medical Bioinformatics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany. 10. Research and Development, Metabolon, Inc., Morrisville, North Carolina; and. 11. Division of Nephrology, Tufts Medical Center, Boston, Massachusetts. 12. Welch Center for Prevention, Epidemiology, and Clinical Research, mgrams2@jhmi.edu. 13. Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Abstract
BACKGROUND AND OBJECTIVES: Data are scarce on blood metabolite associations with proteinuria, a strong risk factor for adverse kidney outcomes. We sought to investigate associations of proteinuria with serum metabolites identified using untargeted profiling in populations with CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using stored serum samples from the African American Study of Kidney Disease and Hypertension (AASK; n=962) and the Modification of Diet in Renal Disease (MDRD) study (n=620), two rigorously conducted clinical trials with per-protocol measures of 24-hour proteinuria and GFR, we evaluated cross-sectional associations between urine protein-to-creatinine ratio and 637 known, nondrug metabolites, adjusting for key clinical covariables. Metabolites significantly associated with proteinuria were tested for associations with CKD progression. RESULTS: In the AASK and the MDRD study, respectively, the median urine protein-to-creatinine ratio was 80 (interquartile range [IQR], 28-359) and 188 (IQR, 54-894) mg/g, mean age was 56 and 52 years, 39% and 38% were women, 100% and 7% were black, and median measured GFR was 48 (IQR, 35-57) and 28 (IQR, 18-39) ml/min per 1.73 m2. Linear regression identified 66 serum metabolites associated with proteinuria in one or both studies after Bonferroni correction (P<7.8×10-5), 58 of which were statistically significant in a meta-analysis (P<7.8×10-4). The metabolites with the lowest P values (P<10-27) were 4-hydroxychlorthalonil and 1,5-anhydroglucitol; all six quantified metabolites in the phosphatidylethanolamine pathway were also significant. Of the 58 metabolites associated with proteinuria, four were associated with ESKD in both the AASK and the MDRD study. CONCLUSIONS: We identified 58 serum metabolites with cross-sectional associations with proteinuria, some of which were also associated with CKD progression. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_02_07_CJASNPodcast_19_03_.mp3.
BACKGROUND AND OBJECTIVES: Data are scarce on blood metabolite associations with proteinuria, a strong risk factor for adverse kidney outcomes. We sought to investigate associations of proteinuria with serum metabolites identified using untargeted profiling in populations with CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using stored serum samples from the African American Study of Kidney Disease and Hypertension (AASK; n=962) and the Modification of Diet in Renal Disease (MDRD) study (n=620), two rigorously conducted clinical trials with per-protocol measures of 24-hour proteinuria and GFR, we evaluated cross-sectional associations between urine protein-to-creatinine ratio and 637 known, nondrug metabolites, adjusting for key clinical covariables. Metabolites significantly associated with proteinuria were tested for associations with CKD progression. RESULTS: In the AASK and the MDRD study, respectively, the median urine protein-to-creatinine ratio was 80 (interquartile range [IQR], 28-359) and 188 (IQR, 54-894) mg/g, mean age was 56 and 52 years, 39% and 38% were women, 100% and 7% were black, and median measured GFR was 48 (IQR, 35-57) and 28 (IQR, 18-39) ml/min per 1.73 m2. Linear regression identified 66 serum metabolites associated with proteinuria in one or both studies after Bonferroni correction (P<7.8×10-5), 58 of which were statistically significant in a meta-analysis (P<7.8×10-4). The metabolites with the lowest P values (P<10-27) were 4-hydroxychlorthalonil and 1,5-anhydroglucitol; all six quantified metabolites in the phosphatidylethanolamine pathway were also significant. Of the 58 metabolites associated with proteinuria, four were associated with ESKD in both the AASK and the MDRD study. CONCLUSIONS: We identified 58 serum metabolites with cross-sectional associations with proteinuria, some of which were also associated with CKD progression. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_02_07_CJASNPodcast_19_03_.mp3.
Authors: Casey M Rebholz; Morgan E Grams; Yuan Chen; Alden L Gross; Yingying Sang; Josef Coresh; Elizabeth Selvin Journal: Am J Epidemiol Date: 2017-10-15 Impact factor: 4.897
Authors: H Shimizu; A Shouzu; M Nishikawa; S Omoto; T Hayakawa; Y Miyake; T Yonemoto; M Inada Journal: Ann Clin Biochem Date: 1999-11 Impact factor: 2.057
Authors: John B Buse; Jennifer L R Freeman; Steven V Edelman; Lois Jovanovic; Janet B McGill Journal: Diabetes Technol Ther Date: 2003 Impact factor: 6.118
Authors: Fabian Dorninger; Alexander Brodde; Nancy E Braverman; Ann B Moser; Wilhelm W Just; Sonja Forss-Petter; Britta Brügger; Johannes Berger Journal: Biochim Biophys Acta Date: 2014-11-15
Authors: Farsad Afshinnia; Viji Nair; Jiahe Lin; Thekkelnaycke M Rajendiran; Tanu Soni; Jaeman Byun; Kumar Sharma; Patrice E Fort; Thomas W Gardner; Helen C Looker; Robert G Nelson; Frank C Brosius; Eva L Feldman; George Michailidis; Matthias Kretzler; Subramaniam Pennathur Journal: JCI Insight Date: 2019-11-01
Authors: Eugene P Rhee; Aditya Surapaneni; Zihe Zheng; Linda Zhou; Diptavo Dutta; Dan E Arking; Jingning Zhang; ThuyVy Duong; Nilanjan Chatterjee; Shengyuan Luo; Pascal Schlosser; Rupal Mehta; Sushrut S Waikar; Santosh L Saraf; Tanika N Kelly; Lee L Hamm; Panduranga S Rao; Anna V Mathew; Chi-Yuan Hsu; Afshin Parsa; Ramachandran S Vasan; Paul L Kimmel; Clary B Clish; Josef Coresh; Harold I Feldman; Morgan E Grams Journal: Kidney Int Date: 2022-02-01 Impact factor: 10.612
Authors: Noha A Yousri; Karsten Suhre; Esraa Yassin; Alya Al-Shakaki; Amal Robay; Maha Elshafei; Omar Chidiac; Steven C Hunt; Ronald G Crystal; Khalid A Fakhro Journal: Diabetes Date: 2022-02-01 Impact factor: 9.461
Authors: Shengyuan Luo; Elena V Feofanova; Adrienne Tin; Sarah Tung; Eugene P Rhee; Josef Coresh; Dan E Arking; Aditya Surapaneni; Pascal Schlosser; Yong Li; Anna Köttgen; Bing Yu; Morgan E Grams Journal: Kidney Int Date: 2021-04-08 Impact factor: 18.998
Authors: Shengyuan Luo; Aditya Surapaneni; Zihe Zheng; Eugene P Rhee; Josef Coresh; Adriana M Hung; Girish N Nadkarni; Bing Yu; Eric Boerwinkle; Adrienne Tin; Dan E Arking; Inga Steinbrenner; Pascal Schlosser; Anna Köttgen; Morgan E Grams Journal: Clin J Am Soc Nephrol Date: 2020-12-31 Impact factor: 8.237
Authors: Michelle R Denburg; Yunwen Xu; Alison G Abraham; Josef Coresh; Jingsha Chen; Morgan E Grams; Harold I Feldman; Paul L Kimmel; Casey M Rebholz; Eugene P Rhee; Ramachandran S Vasan; Bradley A Warady; Susan L Furth Journal: Clin J Am Soc Nephrol Date: 2021-08 Impact factor: 10.614